Note: This document contains side effect information about crizotinib. Some dosage forms listed on this page may not apply to the brand name Xalkori.

Summary

Common side effects of Xalkori include: increased serum alanine aminotransferase. Continue reading for a comprehensive list of adverse effects.

Applies to crizotinib: oral capsules.

Side effects include:

ALK-positive metastatic NSCLC (≥25%): Vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated aminotransferase concentrations, fatigue, decreased appetite, upper respiratory infection, dizziness, neuropathy.

ALCL (≥35%): Diarrhea, vomiting, nausea, vision disorder, headache, musculoskeletal pain, stomatitis, fatigue, decreased appetite, pyrexia, abdominal pain, cough, pruritus.

Grade 3 or 4 laboratory abnormalities (≥15%): Neutropenia, lymphopenia, thrombocytopenia.

For Healthcare Professionals

Applies to crizotinib: oral capsule.

Ocular

Very common (10% or more): Vision disorders (e.g., diplopia, photophobia, photopsia, reduced visual acuity, blurred vision, vitreous floaters, visual impairment) (71%), ocular hypotension (19%)

Uncommon (0.1% to 1%): Severe vision loss^[Ref]

Cardiovascular

Very common (10% or more): Bradycardia (19%)

Common (1% to 10%): QT interval prolongation, cardiac failure (e.g., cardiac failure, cardiac failure congestive, ejection fraction decreased, left ventricular failure, pulmonary edema), syncope^[Ref]

Hepatic

Very common (10% or more): ALT elevation (79%), AST elevation (66%), increased alkaline phosphatase (19%)

Common (1% to 10%): Hepatic failure, increased gamma-glutamyl transferase^[Ref]

Hematologic

Very common (10% or more): Neutropenia (22%), lymphopenia (18%), leukopenia (15%), anemia (15%)

Common (1% to 10%): Febrile neutropenia^[Ref]

Respiratory

Very common (10% or more): Upper respiratory infection (e.g., nasopharyngitis, pharyngitis, rhinitis, upper respiratory tract infection) (32%)

Common (1% to 10%): Pulmonary embolism, interstitial lung disease^[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (61%), nausea (57%), vomiting (46%), constipation (43%), abdominal pain (26%), dyspepsia (14%), dysphagia (10%)

Common (1% to 10%): Esophagitis^[Ref]

Dermatologic

Very common (10% or more): Rash (13%)^[Ref]

General

The most common adverse reactions (25% or more) are vision disorders, nausea, diarrhea, vomiting, constipation, edema, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy.^[Ref]

Metabolic

Very common (10% or more): Hypophosphatemia (up to 32%), decreased appetite (27%), hypokalemia (18%), decreased weight (10%), hypernatremia (19%), hyponatremia (12%), hyperuricemia (12%)

Common (1% to 10%): Decreased blood testosterone (e.g., blood testosterone decreased, hypogonadism, secondary hypogonadism)

Uncommon (0.1% to 1%): Increased weight^[Ref]

Nervous system

Very common (10% or more): Dysgeusia (26%), dizziness (e.g., balance disorder, dizziness, dizziness postural, presyncope) (26%), neuropathy (e.g., burning sensation, dysesthesia, formication, gait disturbance, hyperesthesia, hypoesthesia, hypotonia, motor dysfunction, muscle atrophy, muscular weakness, neuralgia, neuritis, neuropathy peripheral, neurotoxicity, paresthesia, peripheral motor neuropathy, peripheral sensorimotor neuropathy, peripheral sensory neuropathy, peroneal nerve palsy, polyneuropathy, sensory disturbance, skin burning sensation) (25%)^[Ref]

Other

swelling, localized edema, peripheral edema, periorbital edema (49%), fatigue (30%), pyrexia (19%)^[Ref]

Renal

Common (1% to 10%): Renal cyst (e.g., renal abscess, renal cyst, renal cyst hemorrhage, renal cyst infection), acute renal injury^[Ref]

Musculoskeletal

Very common (10% or more): Pain in extremity (16%)

Common (1% to 10%): Muscle spasm, muscular weakness^[Ref]